Citi cuts Lenz Therapeutics price target to $10 on slow sales

August 12, 2026 6:28 AM

Citi analyst Yigal Nochomovitz lowered his price target on Lenz Therapeutics (NASDAQ: LENZ) to $10.00 from $20.00, while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found